Awesome Goat digests the web for you.
Home

Featured Reads

The Goat Timeline
Browse all public reads
Read the docs
Blog
Sign In

Adyen NV (ADYEY-OTC, $8.47 US). An EBITDA Decline Does Not Equate to a Change in my Investment Thesis.

gnosticcapital.com / Blog Archives

Adyen NV (ADYEY-OTC, $8.47 US). An EBITDA Decline Does Not Equate to a Change in my Investment Thesis.

Posted on August 28, 2023 by Randolph McDuff — No Comments ↓

(EU converted to USD at the rate of 1.0868 as of 06/30/2023). Adyen NV, the fast growing publicly traded payment processor, reported a very disappointing first half 2023 fiscal result. Net revenues, at $803.2 million US, increased by 8.9% as…

Read more ›

Posted in Open Blog

published over 1 year ago



Previous

Novo Nordisk (NVO-NYSE, $187.57) and Eli Lilly (LLY-NYSE, $517.53) Seek to Potentially Upend Modern Preventative Healthcare. There Will be Winners and Losers.
published almost 2 years ago

Next

Grupo Comercial Chedraui (CHDRAUIB-MX, $5.92) to be Added to the S&P/BMV IPC Equity Index Effective 09/18/23.
published over 1 year ago

See all items from the same source

Nothing in this site constitutes investment, legal, tax or other advice and it is not to be relied upon in making any investment decision.

This site is under active development and it is nowhere near what I would consider alpha version.

Awesome Goat ߦ 2024 Follow on Twitter

Cookie policy: There are no cokies. Except for user authentication.

There are no Site Analytics. I have no idea what you do.

Visual Design is known weakness. Priority is function over form.

Popular Social Media site feeds are under development.

Thank You for using Awesome Goat.